| Year |
Title |
Altmetric |
| 2022
|
Employment status at transplant influences ethnic disparities in outcomes after deceased donor kidney transplantation.
BMC Nephrology.
23.
2022
|
|
| 2022
|
Genetic regulation of serum IgA levels and susceptibility to common immune, infectious, kidney, and cardio-metabolic traits.
Nature Communications.
13.
2022
|
|
| 2022
|
Associations between female birth sex and risk of chronic kidney disease development among people with HIV in the USA: A longitudinal, multicentre, cohort study.
EClinicalMedicine.
53.
2022
|
|
| 2021
|
Iga vasculitis with nephritis in adults: Histological and clinical assessment.
Journal of Clinical Medicine.
10.
2021
|
|
| 2021
|
Mesangioproliferative Kidney Diseases and Platelet-Derived Growth Factor–Mediated AXL Phosphorylation.
Kidney Medicine.
3:1003-1013.e1.
2021
|
|
| 2021
|
Pathogenesis of iga nephropathy: Current understanding and implications for development of disease-specific treatment.
Journal of Clinical Medicine.
10.
2021
|
|
| 2021
|
Experimental evidence of pathogenic role of IgG autoantibodies in IgA nephropathy.
Journal of Autoimmunity.
118.
2021
|
|
| 2021
|
IgA Nephropathy: An Interesting Autoimmune Kidney Disease: IgA Nephropathy.
American Journal of the Medical Sciences.
361:176-194.
2021
|
|
| 2021
|
Impact of Subclinical Borderline Inflammation on Kidney Transplant Outcomes.
Transplantation Direct.
7:E663.
2021
|
|
| 2020
|
Genome-wide association study for time to failure of kidney transplants from African American deceased donors.
Clinical Transplantation.
34.
2020
|
|
| 2020
|
Persistent Disease Activity in Patients With Long-Standing Glomerular Disease.
Kidney International Reports.
5:860-871.
2020
|
|
| 2020
|
Leukemia Inhibitory Factor Signaling Enhances Production of Galactose-Deficient IgA1 in IgA Nephropathy..
Kidney Diseases.
6:168-180.
2020
|
|
| 2020
|
APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO): Design and Rationale.
Kidney International Reports.
5:278-288.
2020
|
|
| 2020
|
Role of Epstein-Barr Virus in Pathogenesis and Racial Distribution of IgA Nephropathy.
Frontiers in Immunology.
11.
2020
|
|
| 2020
|
TLR9 activation induces aberrant IgA glycosylation via APRIL- and IL-6–mediated pathways in IgA nephropathy.
Kidney International.
97:340-349.
2020
|
|
| 2020
|
Redefining the Influence of Ethnicity on Simultaneous Kidney and Pancreas Transplantation Outcomes: A 15-year Single-center Experience.
Annals of Surgery.
271:177-183.
2020
|
|
| 2019
|
Autoantibodies Specific for Galactose-Deficient IgA1 in IgA Vasculitis With Nephritis.
Kidney International Reports.
4:1717-1724.
2019
|
|
| 2019
|
Health-related quality of life in glomerular disease.
Kidney International.
95:1209-1224.
2019
|
|
| 2019
|
CureGN Study Rationale, Design, and Methods: Establishing a Large Prospective Observational Study of Glomerular Disease.
American Journal of Kidney Diseases.
73:218-229.
2019
|
|
| 2019
|
Glomerular immunodeposits of patients with IgA nephropathy are enriched for IgG autoantibodies specific for galactose-deficient IgA1.
Journal of the American Society of Nephrology.
30:2017-2026.
2019
|
|
| 2019
|
The emerging role of complement proteins as a target for therapy of IgA nephropathy.
Frontiers in Immunology.
10.
2019
|
|
| 2018
|
Population Health, Ethnicity, and Rate of Living Donor Kidney Transplantation.
Transplantation.
102:2080-2087.
2018
|
|
| 2018
|
Clinical Characteristics and Treatment Patterns of Children and Adults With IgA Nephropathy or IgA Vasculitis: Findings From the CureGN Study.
Kidney International Reports.
3:1373-1384.
2018
|
|
| 2018
|
Secondary IgA nephropathy.
Kidney International.
94:674-681.
2018
|
|
| 2018
|
Aberrant Glycosylation of the IgA1 Molecule in IgA Nephropathy.
Seminars in Nephrology.
38:461-476.
2018
|
|
| 2018
|
Genome-wide association studies suggest that APOL1-environment interactions more likely trigger kidney disease in African Americans with nondiabetic nephropathy than strong APOL1–second gene interactions.
Kidney International.
94:599-607.
2018
|
|
| 2018
|
Assay for galactose-deficient IgA1 enables mechanistic studies with primary cells from IgA nephropathy patients
2018
|
|
| 2018
|
Apolipoprotein L1 and Chronic Kidney Disease Risk in Young Potential Living Kidney Donors.
Annals of Surgery.
267:1161-1168.
2018
|
|
| 2018
|
Evaluation of potential living kidney donors in the APOL1 era.
Journal of the American Society of Nephrology.
29:1079-1081.
2018
|
|
| 2018
|
Life Expectancy for Patients From the Southeastern United States With IgA Nephropathy.
Kidney International Reports.
3:99-104.
2018
|
|
| 2018
|
Serum galactose-deficient-IgA1 and IgG autoantibodies correlate in patients with IgA nephropathy.
PLoS One.
13.
2018
|
|
| 2017
|
Noninvasive diagnosis of chronic kidney diseases using urinary proteome analysis.
Nephrology Dialysis Transplantation.
32:2079-2089.
2017
|
|
| 2017
|
Apolipoprotein L1 Gene Effects on Kidney Transplantation.
Seminars in Nephrology.
37:530-537.
2017
|
|
| 2017
|
Influence of Kidney Transplant Status on Warfarin Dose, Anticoagulation Control, and Risk of Hemorrhage
2017
|
|
| 2017
|
Effect of Replacing Race With Apolipoprotein L1 Genotype in Calculation of Kidney Donor Risk Index.
American Journal of Transplantation.
17:1540-1548.
2017
|
|
| 2017
|
Prognostic value of serum biomarkers of autoimmunity for recurrence of IGA nephropathy after kidney transplantation.
Journal of the American Society of Nephrology.
28:1943-1950.
2017
|
|
| 2017
|
A randomized, controlled trial of rituximab in IgA nephropathy with proteinuria and renal dysfunction.
Journal of the American Society of Nephrology.
28:1306-1313.
2017
|
|
| 2017
|
GWAS for serum galactose-deficient IgA1 implicates critical genes of the O-glycosylation pathway.
PLoS Genetics.
13.
2017
|
|
| 2017
|
Evidence from the Oxford Classification cohort supports the clinical value of subclassification of focal segmental glomerulosclerosis in IgA nephropathy.
Kidney International.
91:235-243.
2017
|
|
| 2017
|
Inhibition of STAT3 Signaling Reduces IgA1 Autoantigen Production in IgA Nephropathy.
Kidney International Reports.
2:1194-1207.
2017
|
|
| 2017
|
Serial Galactose-Deficient IgA1 Levels in Children with IgA Nephropathy and Healthy Controls.
International Journal of Nephrology.
2017.
2017
|
|
| 2016
|
The origin and activities of IgA1-containing immune complexes in IGA nephropathy.
Frontiers in Immunology.
7.
2016
|
|
| 2016
|
Deceased-donor apolipoprotein L1 renal-risk variants have minimal effects on liver transplant outcomes.
PLoS One.
11.
2016
|
|
| 2016
|
APOL1 genotype and kidney transplantation outcomes from deceased african American donors.
Transplantation.
100:194-202.
2016
|
|
| 2016
|
Galactose-Deficient IgA1 as a Candidate Urinary Polypeptide Marker of IgA Nephropathy?.
Disease Markers.
2016.
2016
|
|
| 2016
|
Somatic mutations modulate autoantibodies against galactose-deficient IgA1 in IgA nephropathy.
Journal of the American Society of Nephrology.
27:3278-3284.
2016
|
|
| 2016
|
The MEST score provides earlier risk prediction in lgA nephropathy.
Kidney International.
89:167-175.
2016
|
|
| 2016
|
Toward Noninvasive Diagnosis of IgA Nephropathy: A Pilot Urinary Metabolomic and Proteomic Study.
Disease Markers.
2016.
2016
|
|
| 2015
|
Deceased donor multidrug resistance protein 1 and caveolin 1 gene variants may influence allograft survival in kidney transplantation.
Kidney International.
88:584-592.
2015
|
|
| 2015
|
Current understanding of the role of complement in IgA nephropathy.
Journal of the American Society of Nephrology.
26:1503-1512.
2015
|
|
| 2015
|
Apolipoprotein L1 gene variants in deceased organ donors are associated with renal allograft failure.
American Journal of Transplantation.
15:1615-1622.
2015
|
|
| 2015
|
New Insights into the Pathogenesis of IgA Nephropathy..
Kidney Diseases.
1:8-18.
2015
|
|
| 2015
|
Should kidney donors be genotyped for APOL1 risk alleles?.
Kidney International.
87:671-673.
2015
|
|
| 2015
|
N-Acetylgalactosaminide α2,6-sialyltransferase II is a candidate enzyme for sialylation of galactose-deficient IgA1, the key autoantigen in IgA nephropathy.
Nephrology Dialysis Transplantation.
30:234-238.
2015
|
|
| 2014
|
Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens.
Nature Genetics.
46:1187-1196.
2014
|
|
| 2014
|
Cellular Signaling and Production of Galactose-Deficient IgA1 in IgA Nephropathy, an Autoimmune Disease.
Journal of Immunology Research.
2014.
2014
|
|
| 2014
|
Enzymatic sialylation of IgA1 O-glycans: Implications for studies of IgA nephropathy.
PLoS One.
9.
2014
|
|
| 2014
|
A panel of serum biomarkers differentiates IgA nephropathy from other renal diseases.
PLoS One.
9.
2014
|
|
| 2014
|
Immune profile of IgA-dominant diffuse proliferative glomerulonephritis.
Clinical Kidney Journal.
7:479-483.
2014
|
|
| 2014
|
Cytokines alter IgA1 O-glycosylation by dysregulating C1GalT1 and ST6GalNAc-II enzymes.
Journal of Biological Chemistry.
289:5330-5339.
2014
|
|
| 2014
|
End-stage renal disease in African Americans with lupus nephritis is associated with APOL1.
Arthritis and Rheumatology.
66:390-396.
2014
|
|
| 2013
|
Biomarkers in IgA nephropathy: Relationship to pathogenetic hits.
Expert Opinion on Medical Diagnostics.
7:615-627.
2013
|
|
| 2013
|
Pathogenesis of immunoglobulin A nephropathy.
Current Opinion in Nephrology and Hypertension.
22:287-294.
2013
|
|
| 2013
|
IgA nephropathy: Molecular mechanisms of the disease.
Annual Review of Pathology: Mechanisms of Disease.
8:217-240.
2013
|
|
| 2013
|
MEdical progress: IgA nephropathy.
New England Journal of Medicine.
368:2402-2414.
2013
|
|
| 2012
|
The IgA1 immune complex-mediated activation of the MAPK/ERK kinase pathway in mesangial cells is associated with glomerular damage in IgA nephropathy.
Kidney International.
82:1284-1296.
2012
|
|
| 2012
|
Association of IgG co-deposition with serum levels of galactose-deficient IgA1 in pediatric IgA nephropathy..
Clinical Nephrology.
78:465-469.
2012
|
|
| 2012
|
In vitro-generated immune complexes containing galactose-deficient IgA1 stimulate proliferation of mesangial cells.
Results in Immunology.
2:166-172.
2012
|
|
| 2012
|
Serum galactose-deficient IgA1 level is not associated with proteinuria in children with IgA nephropathy.
International Journal of Nephrology.
2012.
2012
|
|
| 2012
|
Autoantibodies targeting galactose-deficient IgA1 associate with progression of IgA nephropathy.
Journal of the American Society of Nephrology.
23:1579-1587.
2012
|
|
| 2012
|
Geographic differences in genetic susceptibility to IgA nephropathy: GWAS replication study and geospatial risk analysis.
PLoS Genetics.
8.
2012
|
|
| 2012
|
Reply to "genetic determinants of mycophenolate-related anemia and leukopenia after transplantation".
Transplantation.
93.
2012
|
|
| 2012
|
Glycosylation of IgA1 and pathogenesis of IgA nephropathy
2012
|
|
| 2012
|
Naturally occurring structural isomers in serum IgA1 O -glycosylation.
Journal of Proteome Research.
11:692-702.
2012
|
|
| 2012
|
Association of IgG co-deposition with serum levels of galactose-deficient IgA1 in pediatric IgA nephropathy.
Clinical Nephrology.
78:465-469.
2012
|
|
| 2012
|
Erratum: Mice overexpressing BAFF develop a commensal flora-dependent, IgA-associated nephropathy (Journal of Clinical Investigation (2011) 121, 10 (3991-4002) DOI: 10.1172/JCI45563).
Journal of Clinical Investigation.
122:778.
2012
|
|
| 2011
|
Membrane-assisted online renaturation for automated microfluidic lectin blotting.
Journal of the American Chemical Society.
133:19610-19613.
2011
|
|
| 2011
|
Sugars and alcohol: IgA-associated renal diseases in alcoholic cirrhosis.
Kidney International.
80:1252-1254.
2011
|
|
| 2011
|
APOL1 variants increase risk for FSGS and HIVAN but not IgA nephropathy.
Journal of the American Society of Nephrology.
22:1991-1996.
2011
|
|
| 2011
|
IgA1 immune complexes from pediatric patients with IgA nephropathy activate cultured human mesangial cells.
Nephrology Dialysis Transplantation.
26:3451-3457.
2011
|
|
| 2011
|
Mice overexpressing BAFF develop a commensal flora-dependent, IgA-associated nephropathy.
Journal of Clinical Investigation.
121:3991-4002.
2011
|
|
| 2011
|
The pathophysiology of IgA nephropathy.
Journal of the American Society of Nephrology.
22:1795-1803.
2011
|
|
| 2011
|
Aberrant glycosylation of iga1 and anti-glycan antibodies in iga nephropathy: Role of mucosal immune system.
Advances in oto-rhino-laryngology.
72:60-63.
2011
|
|
| 2011
|
Oxidative stress and galactose-deficient IgA1 as markers of progression in IgA nephropathy.
Clinical Journal of the American Society of Nephrology.
6:1903-1911.
2011
|
|
| 2011
|
Validation of the Oxford classification of IgA nephropathy.
Kidney International.
80:310-317.
2011
|
|
| 2011
|
Genetic determinants of mycophenolate-related anemia and leukopenia after transplantation.
Transplantation.
91:309-316.
2011
|
|
| 2011
|
Novel polymorphisms associated with tacrolimus trough concentrations: Results from a multicenter kidney transplant consortium.
Transplantation.
91:300-308.
2011
|
|
| 2011
|
Genome-wide association study identifies susceptibility loci for IgA nephropathy.
Nature Genetics.
43:321-329.
2011
|
|
| 2011
|
Aberrant glycosylation of IgA1 is inherited in both pediatric IgA nephropathy and Henoch-Schönlein purpura nephritis.
Kidney International.
80:79-87.
2011
|
|
| 2010
|
Clustered O-glycans of IgA1: Defining macro- and microheterogeneity by use of electron capture/transfer dissociation.
Molecular and Cellular Proteomics.
9:2545-2557.
2010
|
|
| 2010
|
Galactose-deficient IgA1 in African Americans with IgA nephropathy: Serum levels and heritability.
Clinical Journal of the American Society of Nephrology.
5:2069-2074.
2010
|
|
| 2010
|
Genetic studies of IgA nephropathy: Past, present, and future.
Pediatric Nephrology.
25:2257-2268.
2010
|
|
| 2010
|
Recommendations for biomarker identification and qualification in clinical proteomics.
Science Translational Medicine.
2.
2010
|
|
| 2010
|
Recognition of galactose-deficient O-glycans in the hinge region of IgA1 by N-acetylgalactosamine-specific snail lectins: A comparative binding study..
Biochemistry.
49:5671-5682.
2010
|
|
| 2010
|
Glomerulonephritis after hematopoietic cell transplantation: IgA nephropathy with increased excretion of galactose-deficient IgA1.
Nephrology Dialysis Transplantation.
25:1708-1713.
2010
|
|
| 2010
|
Tissue distribution and biological activities of immune complexes are determined by their size and composition.
Nephrology Dialysis Transplantation.
25:1007.
2010
|
|
| 2010
|
Familial IgA nephropathy in southeastern Kentucky..
Clinical Nephrology.
73:115-121.
2010
|
|
| 2010
|
Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease.
Molecular and Cellular Proteomics.
9:2424-2437.
2010
|
|
| 2010
|
The Oxford IgA nephropathy clinicopathological classification is valid for children as well as adults.
Kidney International.
77:921-927.
2010
|
|
| 2009
|
Application of proteomic analysis to renal disease in the clinic
2009
|
|
| 2009
|
Sources of urinary proteins and their analysis by urinary proteomics for the detection of biomarkers of disease
2009
|
|
| 2009
|
Risk factors and impact of recurrent lupus nephritis in patients with systemic lupus erythematosus undergoing renal transplantation: Data from a single US institution.
Arthritis and Rheumatism.
60:2757-2766.
2009
|
|
| 2009
|
The Oxford classification of IgA nephropathy: Pathology definitions, correlations, and reproducibility.
Kidney International.
76:546-556.
2009
|
|
| 2009
|
The Oxford classification of IgA nephropathy: Rationale, clinicopathological correlations, and classification.
Kidney International.
76:534-545.
2009
|
|
| 2009
|
Secondary listing for deceased-donor kidney transplantation does not increase likelihood of engraftment at a large transplant center: Brief communication.
American Journal of Transplantation.
9:1671-1673.
2009
|
|
| 2009
|
Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity.
Journal of Clinical Investigation.
119:1668-1677.
2009
|
|
| 2009
|
Isolated central nervous system posttransplant lymphoproliferative disorder treated with high-dose intravenous methotrexate.
American Journal of Transplantation.
9:1243-1248.
2009
|
|
| 2008
|
CE-MS analysis of the human urinary proteome for biomarker discovery and disease diagnostics
2008
|
|
| 2008
|
Urinary proteomics in diabetes and CKD.
Journal of the American Society of Nephrology.
19:1283-1290.
2008
|
|
| 2008
|
Systolic dysfunction portends increased mortality among those waiting for renal transplant.
Journal of the American Society of Nephrology.
19:1190-1196.
2008
|
|
| 2008
|
Aberrant IgA1 glycosylation is inherited in familial and sporadic IgA nephropathy.
Journal of the American Society of Nephrology.
19:1008-1014.
2008
|
|
| 2008
|
IgA1-secreting cell lines from patients with IgA nephropathy produce aberrantly glycosylated IgA1.
Journal of Clinical Investigation.
118:629-639.
2008
|
|
| 2008
|
Role of aberrant glycosylation of IgA1 molecules in the pathogenesis of iga nephropathy.
Kidney and Blood Pressure Research.
31:29-37.
2008
|
|
| 2008
|
IgA Glycosylation and IgA Immune Complexes in the Pathogenesis of IgA Nephropathy.
Seminars in Nephrology.
28:78-87.
2008
|
|
| 2007
|
Electrophoretic methods for analysis of urinary polypeptides in lgA-associated renal diseases.
Electrophoresis.
28:4469-4483.
2007
|
|
| 2007
|
Serum levels of galactose-deficient IgA in children with IgA nephropathy and Henoch-Schönlein purpura.
Pediatric Nephrology.
22:2067-2072.
2007
|
|
| 2007
|
Analysis of O-glycan heterogeneity in IgA1 myeloma proteins by Fourier transform ion cyclotron resonance mass spectrometry: Implications for IgA nephropathy.
Analytical and Bioanalytical Chemistry.
389:1397-1407.
2007
|
|
| 2007
|
Urinary biomarkers of IgA nephropathy and other IgA-associated renal diseases.
World Journal of Urology.
25:467-476.
2007
|
|
| 2007
|
High-resolution proteome/peptidome analysis of peptides and low-molecular-weight proteins in urine
2007
|
|
| 2007
|
Patients with IgA nephropathy have increased serum galactose-deficient IgA1 levels.
Kidney International.
71:1148-1154.
2007
|
|
| 2007
|
The genetics of IgA nephropathy.
Nature Reviews Nephrology.
3:325-338.
2007
|
|
| 2007
|
IgA nephropathy and henoch-schoenlein purpura nephritis: Aberrant glycosylation of IgA1, formation of IgA1-containing immune complexes, and activation of mesangial cells.
Contributions to Nephrology.
157:134-138.
2007
|
|
| 2007
|
IgA nephropathy: A clinical overview.
Contributions to Nephrology.
157:19-26.
2007
|
|
| 2007
|
IgA nephropathy: Characterization of IgG antibodies specific for galactose-deficient IgA1.
Contributions to Nephrology.
157:129-133.
2007
|
|
| 2007
|
IgA nephropathy: Current views of immune complex formation.
Contributions to Nephrology.
157:56-63.
2007
|
|
| 2007
|
Identification and Characterization of CMP-NeuAc:GalNAc-IgA1 α2,6-Sialyltransferase in IgA1-producing Cells.
Journal of Molecular Biology.
369:69-78.
2007
|
|
| 2007
|
Reactivities of N-acetylgalactosamine-specific lectins with human IgA1 proteins.
Molecular Immunology.
44:2598-2604.
2007
|
|
| 2007
|
Clinical proteomics: A need to define the field and to begin to set adequate standards
2007
|
|
| 2006
|
IgA-containing immune complexes in the urine of IgA nephropathy patients.
Nephrology Dialysis Transplantation.
21:2478-2484.
2006
|
|
| 2006
|
Brief communication: Glomerulonephritis in patients with hepatitis C cirrhosis undergoing liver transplantation.
ACP journal club.
144:735-741.
2006
|
|
| 2006
|
Clinical trial to evaluate omega-3 fatty acids and alternate day prednisone in patients with IgA nephropathy: report from the Southwest Pediatric Nephrology Study Group..
Clinical Journal of the American Society of Nephrology.
1:467-474.
2006
|
|
| 2005
|
Recurrent IgA nephropathy after renal transplantation despite immunosuppressive regimens with mycophenolate mofetil.
Nephrology Dialysis Transplantation.
20:1214-1221.
2005
|
|
| 2005
|
IgA1-containing immune complexes in IgA nephropathy differentially affect proliferation of mesangial cells.
Kidney International.
67:504-513.
2005
|
|
| 2004
|
IgA nephropathy: An update.
Current Opinion in Nephrology and Hypertension.
13:171-179.
2004
|
|
| 2004
|
Angiotensin II Receptor Type 1 Expression in Erythroid Progenitors: Implications for the Pathogenesis of Postrenal Transplant Erythrocytosis.
Seminars in Nephrology.
24:120-130.
2004
|
|
| 2004
|
Incidence of hip osteonecrosis among renal transplantation recipients: A prospective study.
Clinical Radiology.
59:431-438.
2004
|
|
| 2003
|
Bone mineral density changes within six months of renal transplantation..
Transplantation.
75:49-54.
2003
|
|
| 2002
|
Interactions of human mesangial cells with IgA and IgA-containing immune complexes.
Kidney International.
62:465-475.
2002
|
|
| 2001
|
Progress in molecular and genetic studies of IgA nephropathy.
Journal of Clinical Immunology.
21:310-327.
2001
|
|
| 2001
|
Tolerance in renal transplantation after allogeneic bone marrow transplantation-6-year follow-up.
Transplantation.
71:1681-1683.
2001
|
|
| 2000
|
IgA nephropathy, the most common cause of glomerulonephritis, is linked to 6q22-23.
Nature Genetics.
26:354-357.
2000
|
|
| 2000
|
Treatment of IgA nephropathy.
Seminars in Nephrology.
20:277-285.
2000
|
|
| 2000
|
Posttransplant lymphoproliferative disorder localized near the allograft in renal transplantation.
Transplantation.
69:809-814.
2000
|
|
| 2000
|
Focal posttransplantation lymphoproliferative disorder at the renal allograft hilum.
American Journal of Roentgenology.
175:1417-1422.
2000
|
|
| 2000
|
IgA1 glycosylation and the pathogenesis of IgA nephropathy.
American Journal of Kidney Diseases.
35:551-554.
2000
|
|
| 1999
|
Sirolimus reduces the incidence of acute rejection episodes despite lower cyclosporine doses in caucasian recipients of mismatched primary renal allografts: A phase II trial.
Transplantation.
68:1526-1532.
1999
|
|
| 1999
|
Expression of stem cell factor by osteoblasts in normal and hyperparathyroid bone: Relation to ectopic mast cell differentiation
1999
|
|
| 1999
|
Parathyroid hormone-regulated production of stem cell factor in human osteoblasts and osteoblast-like cells.
Biochemical and Biophysical Research Communications.
255:778-784.
1999
|
|
| 1999
|
Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies.
Journal of Clinical Investigation.
104:73-81.
1999
|
|
| 1999
|
Progress in the pathogenesis of IgA nephropathy..
Advances in nephrology from the Necker Hospital.
29:53-72.
1999
|
|
| 1999
|
Treatment of immunoglobulin A nephropathy.
Presse Médicale.
150:127-136.
1999
|
|
| 1998
|
Losartan, an Angiotensin II type 1 receptor antagonist, lowers hematocrit in posttransplant erythrocytosis.
Journal of the American Society of Nephrology.
9:1104-1108.
1998
|
|
| 1998
|
Epidemiology of IgA nephropathy in central and eastern Kentucky for the period 1975 through 1994.
Journal of the American Society of Nephrology.
9:853-858.
1998
|
|
| 1998
|
Late expression of tumor necrosis factor-α is markedly depressed in patients with IgA nephropathy
1998
|
|
| 1997
|
Renal transplantation in African-American recipients: three decades at a single center..
Transplantation Proceedings.
29:3726-3728.
1997
|
|
| 1997
|
Angiotensin II stimulates proliferation of normal early erythroid progenitors.
Journal of Clinical Investigation.
100:2310-2314.
1997
|
|
| 1997
|
Galactose-deficient IgA1 in sera of IgA nephropathy patients is present in complexes with IgG.
Kidney International.
52:509-516.
1997
|
|
| 1997
|
Human peritoneal B-1 cells and the influence of continuous ambulatory peritoneal dialysis on peritoneal and peripheral blood mononuclear cell (PBMC) composition and immunoglobulin levels.
Clinical and Experimental Immunology.
109:356-361.
1997
|
|
| 1997
|
The impact of renal transplantation on survival in hepatitis C- positive end-stage renal disease patients.
American Journal of Kidney Diseases.
29:608-614.
1997
|
|
| 1996
|
Amlodipine increases cyclosporine levels in hypertensive renal transplant patients: Results of a prospective study.
Journal of the American Society of Nephrology.
7:831-835.
1996
|
|
| 1996
|
Impact of donor/recipient size matching on outcomes in renal transplantation.
Transplantation.
61:383-388.
1996
|
|
| 1996
|
Angiotensin converting enzyme gene polymorphism: Potential silencer motif and impact on progression in IgA nephropathy.
Kidney International.
49:571-577.
1996
|
|
| 1996
|
Benefits of continued cyclosporine through an indigent drug program.
American Journal of Kidney Diseases.
28:572-577.
1996
|
|
| 1996
|
Dilemmas in renal transplantation: When the clinical course and histological findings differ.
American Journal of Kidney Diseases.
27:435-440.
1996
|
|
| 1996
|
IgA nephropathy: Defect of glycosylation of IgA1 molecules.
Journal of Investigative Medicine.
44.
1996
|
|
| 1995
|
Complications of the musculoskeletal system in renal transplant recipients.
Journal of Nephrology.
8:231-237.
1995
|
|
| 1995
|
IgA nephropathy: A disease of incomplete IgA 1 glycosylation?.
Advances in Experimental Medicine and Biology.
376:221-222.
1995
|
|
| 1995
|
Intraperitoneal administration of tetanus toxoid elicits a specific responses of antibody-secreting cells in the peritoneal cavity.
Advances in Experimental Medicine and Biology.
371:103-106.
1995
|
|
| 1995
|
Progress in Renal Transplantation a Single Center Study of 3359 Patients over 25 Years.
Annals of Surgery.
221:446-458.
1995
|
|
| 1994
|
Hemolytically inactive C4B complement allotype caused by a proline to leucine mutation in the C5-binding site.
Journal of Biological Chemistry.
269:27727-27731.
1994
|
|
| 1994
|
Erythropoiesis after withdrawal of enalapril in post-transplant erythrocytosis.
Kidney International.
46:1397-1403.
1994
|
|
| 1994
|
Immunological studies of IgA nephropathy in blacks reveal elevations of serum IgA2 as well as IgA1.
Nephrology Dialysis Transplantation.
9:1324-1329.
1994
|
|
| 1994
|
Intraperitoneal immunization of human subjects with tetanus toxoid induces specific antibody-secreting cells in the peritoneal cavity and in the circulation, but fails to elicit a secretory IgA response.
Clinical and Experimental Immunology.
96:356-363.
1994
|
|
| 1994
|
Posttransplant Erythrocytosis: An Enigma Revisited.
American Journal of Kidney Diseases.
24:1-11.
1994
|
|
| 1994
|
Renal retransplantation: The role of race, quadruple immunosuppression, and the flow cytometry cross-match.
Transplantation.
57:47-54.
1994
|
|
| 1993
|
Captopril-induced fall in glomerular filtration rate in cyclosporine-treated hypertensive patients.
Journal of the American Society of Nephrology.
3:1570-1574.
1993
|
|
| 1993
|
Alternate-day prednisone therapy in IgA nephropathy. Preliminary analysis of a prospective, randomized, controlled trial..
Contributions to Nephrology.
104:198-206.
1993
|
|
| 1993
|
Bone loss after organ transplantation.
Transplantation Reviews.
7:82-95.
1993
|
|
| 1993
|
Defective galactosylation and clearance of IgA1 molecules as a possible etiopathogenic factor in IgA nephropathy..
Contributions to Nephrology.
104:172-182.
1993
|
|
| 1993
|
Experience with mycophenolate mofetil (RS61443) in renal transplantation at a single center.
Annals of Surgery.
217:476-484.
1993
|
|
| 1993
|
Immunoglobulin A-Fibronectin Aggregate Levels in Children and Adults With Immunoglobulin A Nephropathy.
American Journal of Kidney Diseases.
22:1-4.
1993
|
|
| 1993
|
Metabolic bone disease in renal transplant recipients.
Endocrinologist.
3:415-424.
1993
|
|
| 1993
|
Reply.
American Journal of Kidney Diseases.
21:344.
1993
|
|
| 1993
|
Shared idiotypes in mesangial deposits in IgA nephropathy are not disease-specific.
Kidney International.
44:65-74.
1993
|
|
| 1993
|
Tapering or Discontinuing Cyclosporine for Financial Reasons—A Single-Center Experience.
American Journal of Kidney Diseases.
21:9-15.
1993
|
|
| 1992
|
Benefits of quadruple immunosuppressive therapy in recipients of living related donor kidneys: A review of 855 operations.
Annals of Surgery.
215:606-617.
1992
|
|
| 1992
|
Binding of serum immunoglobulins to collagens in IgA nephropathy and HIV infection.
Kidney International.
42:374-382.
1992
|
|
| 1992
|
Cytokine-Induced Immunoglobulin Production in Primary IgA Nephropathy.
American Journal of Kidney Diseases.
20:611-617.
1992
|
|
| 1992
|
Familial IgA Nephropathy Associated With Bilateral Sensorineural Deafness.
American Journal of Kidney Diseases.
19:592-596.
1992
|
|
| 1992
|
IgA-containing immune complexes after challenge with food antigens in patients with IgA nephropathy.
Clinical and Experimental Immunology.
89:315-320.
1992
|
|
| 1992
|
Improved survival of primary cadaveric renal allografts in blacks with quadruple immunosuppression.
Transplantation.
53:103-109.
1992
|
|
| 1992
|
Musculoskeletal Complications After Renal Transplantation: Pathogenesis and Treatment.
American Journal of Kidney Diseases.
19:99-120.
1992
|
|
| 1992
|
Reply.
American Journal of Kidney Diseases.
20:531.
1992
|
|
| 1992
|
The impact of the UNOS mandatory sharing policy on recipients of the black and white races-experience at a single renal transplant center.
Transplantation.
53:770-774.
1992
|
|
| 1991
|
Rapid loss of vertebral mineral density after renal transplantation.
New England Journal of Medicine.
325:544-550.
1991
|
|
| 1991
|
Are black living-related renal donors at greater long-term risk of renal complications than white donors?.
Transplantation Proceedings.
23:1328-1329.
1991
|
|
| 1991
|
Analysis of 22 years experience in living-related transplantation at the University of Alabama in Birmingham..
Clinical transplants.
179-191.
1991
|
|
| 1991
|
C4A deficiency and poor prognosis in patients with IgA nephropathy.
Clinical Nephrology.
36:1-5.
1991
|
|
| 1991
|
Effects of enalapril on erythrocytosis after renal transplantation.
ACP journal club.
115:954-955.
1991
|
|
| 1991
|
Epstein-Barr virus Transformation of B Lymphocytes From IgA Nephropathy Patients and First-Degree Relatives Results in Increased Immunoglobulin Synthesis not Restricted to IgA.
American Journal of Kidney Diseases.
17:55-61.
1991
|
|
| 1991
|
IgA nephropathy in blacks: Studies of IgA2 allotypes and clinical course.
Kidney International.
39:1218-1224.
1991
|
|
| 1991
|
Long-term results of a controlled prospective study with transfusion of donor-specific bone marrow in 57 cadaveric renal allograft recipients.
Transplantation.
51:70-75.
1991
|
|
| 1991
|
Macroscopic Hematuria and Proteinuria Preceding Renal IgA Deposition in Patients With IgA Nephropathy.
American Journal of Kidney Diseases.
17:472-479.
1991
|
|
| 1991
|
OKT3 first-dose reaction: Association with T cell subsets and cytokine release.
Kidney International.
39:141-148.
1991
|
|
| 1991
|
Role for specific complement phenotypes and deficiencies in the clinical expression of IgA nephropathy.
American Journal of the Medical Sciences.
301:115-123.
1991
|
|
| 1991
|
Selective Elevation of Monomeric IgA1 in IgA Nephropathy Patients With Normal Renal Function.
American Journal of Kidney Diseases.
18:313-319.
1991
|
|
| 1990
|
C4B Deficiency in Two Siblings With IgA Nephropathy.
American Journal of Kidney Diseases.
15:66-71.
1990
|
|
| 1990
|
Cyclosporine-induced changes in glomerular filtration rate and urea excretion.
American Journal of Medicine.
88:497-502.
1990
|
|
| 1990
|
Cyclosporine-induced changes in glomerular filtration rate and urea excretion.
American Journal of Medicine.
88:497-502.
1990
|
|
| 1990
|
Donor antigen-specific immunosuppression in cadaveric and living-related donor kidney allograft recipients..
Clinical transplants.
289-300.
1990
|
|
| 1990
|
J chain disease: A novel form of plasma cell dyscrasia.
American Journal of Medicine.
88:411-416.
1990
|
|
| 1990
|
Regional variation in C4 phenotype in patients with IgA nephropathy.
Journal of Pediatrics.
116.
1990
|
|
| 1989
|
NON-SPECIFIC MESANGIAL STAINING WITH ANTIBODIES AGAINST CYTOMEGALOVIRUS IN IMMUNOGLOBULIN-A NEPHROPATHY
1989
|
|
| 1989
|
Non-specific mesangial staining with antibodies against cytomegalovirus in immunoglobulin-A nephropathy
1989
|
|
| 1989
|
Successful renal allografts in recipients with a positive standard, DTE negative cross-match.
Transplantation Proceedings.
21:746-747.
1989
|
|
| 1989
|
Successful renal allografts in recipients with crossmatch-positive, dithioerythritol-treated negative sera: Race, transplant history, and HLA-DR1 phenotype.
Transplantation.
47:240-245.
1989
|
|
| 1989
|
Sustained high panel reactive antibody levels in highly sensitized patients: Significance of continued transfusions.
Transplantation Proceedings.
21:771-772.
1989
|
|
| 1989
|
Use of cryopreserved donor bone marrow in cadaver kidney allograft recipients.
Transplantation.
47:66-71.
1989
|
|
| 1988
|
A Comparison of OKT3 Monoclonal Antibody and Corticosteroids in the Treatment of Acute Renal Allograft Rejection.
American Journal of Kidney Diseases.
11:86-89.
1988
|
|
| 1988
|
Activation of Complement in IgA Nephropathy.
American Journal of Kidney Diseases.
12:437-442.
1988
|
|
| 1988
|
Bilateral Cavernous Sinus Thrombosis due to Mucormycosis.
JAMA Ophthalmology.
106:1089-1092.
1988
|
|
| 1988
|
Early graft loss in cyclosporine A-treated cadaveric renal allograft recipients receiving retransplants against previous mismatched HLA-A, -B, -DR donor antigens.
Transplantation Proceedings.
20:170-172.
1988
|
|
| 1988
|
Familial Clustering and Immunogenetic Aspects of IgA Nephropathy.
American Journal of Kidney Diseases.
12:366-370.
1988
|
|
| 1988
|
IgA nephropathy, the most common glomerulonephritis worldwide. A neglected disease in the United States?.
American Journal of Medicine.
84:129-132.
1988
|
|
| 1988
|
On the mechanism by which chloride corrects metabolic alkalosis in man.
American Journal of Medicine.
84:449-458.
1988
|
|
| 1987
|
Genetic factors in primary IgA nephropathy.
Nephrology Dialysis Transplantation.
2:134-142.
1987
|
|
| 1987
|
Morphologic and immunohistochemical observations in granulomatous glomerulonephritis.
American Journal of Pathology.
126:581-591.
1987
|
|
| 1987
|
A major gene model for the familial aggregation of plasma IgA concentration.
American Journal of Medical Genetics Part A.
27:857-866.
1987
|
|
| 1987
|
Aberrant synthesis of antibodies directed at the Fab fragment of IgA in patients with IgA nephropathies.
Clinical Immunology.
45:208-213.
1987
|
|
| 1987
|
Analysis of immunoglobulin heavy chain restriction fragment length polymorphisms in IgA nephropathy..
Seminars in Nephrology.
7:306-310.
1987
|
|
| 1987
|
Antibodies directed at Fab of IgA in the sera of normal individuals and IgA nephropathy patients..
Advances in Experimental Medicine and Biology.
216 B:1537-1544.
1987
|
|
| 1987
|
Complement activation in IgA nephropathy.
Kidney International.
31:1019-1023.
1987
|
|
| 1987
|
Complement phenotypes (C3 and C4) in IgA nephropathy..
Advances in Experimental Medicine and Biology.
216 B:1569-1575.
1987
|
|
| 1987
|
Detection of food antigen-specific IgA immune complexes in human sera..
Advances in Experimental Medicine and Biology.
216 A:813-820.
1987
|
|
| 1987
|
Fatal rhizopus infections in hemodialysis patients receiving deferoxamine.
ACP journal club.
107:678-679.
1987
|
|
| 1987
|
IgA-associated renal diseases: immunochemical studies of IgA1 proteins, circulating immune complexes, and cellular interactions..
Seminars in Nephrology.
7:332-335.
1987
|
|
| 1987
|
Immunogenetic markers as prognostic features in patients from Kentucky with IgA nephropathy..
Seminars in Nephrology.
7:389-392.
1987
|
|
| 1987
|
Immunological studies of IgA nephropathy: familial and racial aspects..
Advances in Experimental Medicine and Biology.
216 B:1489-1498.
1987
|
|
| 1987
|
Influence of race on renal allograft survival in the pre- and postcyclosporine era..
Clinical transplants.
217-233.
1987
|
|
| 1987
|
Oxalosis in Bone Causing a Radiographical Mimicry of Renal Osteodystrophy.
American Journal of Kidney Diseases.
9:436-440.
1987
|
|
| 1987
|
Regionalization in hereditary IgA nephropathy.
American Journal of Human Genetics.
41:36-50.
1987
|
|
| 1987
|
Striking Elevation of Serum IgA, IgA-Containing Immune Complexes, and IgA Rheumatoid Factor in Clinically Silent Dermatitis Herpetiformis.
American Journal of Kidney Diseases.
10:378-384.
1987
|
|
| 1986
|
Aluminum-associated renal osteodystrophy..
The Alabama journal of medical sciences.
23:414-419.
1986
|
|
| 1986
|
Aluminum-related bone disease in mild and advanced renal failure: Evidence for high prevalence and morbidity and studies on etiology and diagnosis.
American Journal of Nephrology.
6:275-283.
1986
|
|
| 1986
|
Circulating immune complexes and immunoglobulin A rheumatoid factor in patients with mesangial immunoglobulin A nephropathies.
Journal of Clinical Investigation.
77:1931-1938.
1986
|
|
| 1986
|
IgA-associated renal diseases: Antibodies to environmental antigens in sera and deposition of immunoglobulins and antigens in glomeruli.
Journal of Clinical Immunology.
6:74-86.
1986
|
|
| 1985
|
Familial IgA Nephropathy.
New England Journal of Medicine.
313:186.
1985
|
|
| 1985
|
Familial IgA Nephropathy: Evidence of an Inherited Mechanism of Disease.
New England Journal of Medicine.
312:202-208.
1985
|
|
| 1985
|
Focal Sclerosis of Hypertrophied Glomeruli in Solitary Functioning Kidneys of Humans.
American Journal of Kidney Diseases.
5:226-232.
1985
|
|
| 1985
|
The immunogenetics of IgA nephropathy.
Plasma Therapy and Transfusion Technology.
6:687-704.
1985
|
|
| 1984
|
Complement phenotypes in glomerulonephritis: Increased frequency of homozygous null C4 phenotypes in IgA nephropathy and Henoch-Schonlein purpura.
Kidney International.
26:855-860.
1984
|
|
| 1984
|
IgA Nephropathy: Presentation, Clinical Course, and Prognosis in Children and Adults.
American Journal of Kidney Diseases.
4:192-200.
1984
|
|
| 1984
|
Increased frequency of C3 fast alleles in IgA nephropathy.
Disease Markers.
2:419-428.
1984
|
|
| 1983
|
Serum complement proteins in IgA nephropathy.
Clinical Nephrology.
20:251-258.
1983
|
|
| 1982
|
Partial H (β1H) deficiency and glomerulonephritis in two families.
Journal of Clinical Immunology.
2:110-117.
1982
|
|
| 1982
|
Renin and aldosterone responses to short-term NaCl or NaHCO3 loading in man
1982
|
|
| 1981
|
Properdin Deficiency with IgA Nephropathy.
New England Journal of Medicine.
305:1097.
1981
|
|
